Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2010 | 09-2009 | 09-2008 | 09-2007 | 09-2006 | |
| Sales | 0 | 3,758 | 1,303 | 1,208 | 461 |
| Gross Profit | N/A | 3,758 | 1,303 | 1,208 | 461 |
| Operating Expenses | 5,833 | 23,318 | 36,306 | 38,300 | 18,708 |
| Operating Income | -5,833 | -19,560 | -35,003 | -37,092 | -18,247 |
| Other Income | 1,521 | 416 | 622 | 1,265 | 1,153 |
| Pre-tax Income | -4,312 | -19,145 | -34,381 | -35,827 | -17,094 |
| Net Income Continuous | -4,312 | -19,145 | -26,935 | -29,100 | -17,221 |
| Net Income Discontinuous | -2,645 | -164 | -154 | -831 | -1,777 |
| Minority Interests | -1,183 | 0 | N/A | N/A | N/A |
| Net Income | $-5,774 | $-19,308 | $-27,089 | $-29,931 | $-18,997 |
| EPS Basic Total Ops | -0.90 | -4.30 | -6.90 | -8.30 | -6.00 |
| EPS Basic Continuous Ops | -0.49 | -4.30 | -6.87 | -8.10 | -5.40 |
| EPS Basic Discontinuous Ops | -0.41 | -0.04 | -0.04 | -0.20 | -0.60 |
| EPS Diluted Total Ops | -0.90 | -4.30 | -6.90 | -8.30 | -6.00 |
| EPS Diluted Continuous Ops | -0.49 | -4.30 | -6.87 | -8.10 | -5.40 |
| EPS Diluted Discontinuous Ops | -0.41 | -0.04 | -0.04 | -0.20 | -0.60 |
| EBITDA(a) | $-5,555 | $-18,565 | $-33,869 | $-36,088 | $-17,360 |